Drug application
TRIAMINIC-12 (CHLORPHENIRAMINE MALEATE, PHENYLPROPANOLAMINE HYDROCHLORIDE)
Drugs@FDA NDA 018115 · NOVARTIS
Key facts
| Drug name | TRIAMINIC-12 |
|---|---|
| Active ingredients | CHLORPHENIRAMINE MALEATE, PHENYLPROPANOLAMINE HYDROCHLORIDE |
| Application type | NDA |
| Application number | 018115 |
| Company | NOVARTIS |
| Dosage forms | TABLET, EXTENDED RELEASE, ORAL |
| Strength | 12MG;75MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
At a glance
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.